Medarex to Present at the 26th Annual JPMorgan Healthcare Conference

Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
PRINCETON, N.J., Jan. 3 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX) announced today that it is scheduled to present at the 26th
Annual JPMorgan Healthcare Conference at 10:30 a.m. ET on Tuesday, January 8,
2008.  The event will be webcast live and will be available in the Investor
Relations section of the Medarex Web site at www.medarex.com.  An archived
edition of the presentation will be available following the event.

    About Medarex

    Medarex is a biopharmaceutical company focused on the discovery,
development and potential commercialization of fully human antibody-based
therapeutics to treat life-threatening and debilitating diseases, including
cancer, inflammation, autoimmune disorders and infectious diseases.  Medarex
applies its UltiMAb(R) technology and product development and clinical
manufacturing experience to generate, support and potentially commercialize a
broad range of fully human antibody product candidates for itself and its
partners.  More than 30 of these therapeutic product candidates derived from
Medarex technology are in human clinical testing or have had INDs submitted
for such trials, with seven of the most advanced product candidates currently
in Phase 3 clinical trials or the subject of regulatory applications for
marketing authorization.  Medarex is committed to building value by developing
a diverse pipeline of antibody products to address the world's unmet
healthcare needs.  For more information about Medarex, visit its Web site at
www.medarex.com.

    Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of
Medarex, Inc.  All rights are reserved.

SOURCE  Medarex, Inc.
    -0-                             01/03/2008
    /CONTACT:  Laura S. Choi, Investor Relations, +1-609-430-2880, x2216, or
Jean Mantuano, Corporate Communications, +1-609-430-2880, x2221, both of
Medarex, Inc./
    /Company News On-Call:  http://www.prnewswire.com/comp/108265.html /
    /Web site:  http://www.medarex.com /
    (MEDX)

CO:  Medarex, Inc.; 26th Annual JPMorgan Healthcare Conference
ST:  New Jersey
IN:  MTC BIO HEA IDC
SU:  TDS CCA

SM-DB
-- NETH026 --
0388 01/03/2008 07:00 EST http://www.prnewswire.com